Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Schmidt, Dieter
1999.
Valproate.
p.
223.
Post, Robert M.
1999.
Valproate.
p.
167.
Chappell, Kimberly A
Markowitz, John S
and
Jackson, Cherry W
1999.
Is Valproate Pharmacotherapy Associated with Polycystic Ovaries?.
Annals of Pharmacotherapy,
Vol. 33,
Issue. 11,
p.
1211.
Demir, Ercan
and
Aysun, Sabiha
2000.
Weight gain associated with valproate in childhood.
Pediatric Neurology,
Vol. 22,
Issue. 5,
p.
361.
Devinsky, Orrin
Vuong, Alain
Hammer, Anne
and
Barrett, Pamela S.
2000.
Stable weight during lamotrigine therapy: A review of 32 studies.
Neurology,
Vol. 54,
Issue. 4,
p.
973.
Baptista, Trino
Lacruz, Anny
De Mendoza, Soaira
Guillén, Marcelo Mendoza
Burguera, JoséLuis
De Burguera, Marcela
and
Hernández, Luis
2000.
Endocrine effects of lithium carbonate in healthy premenopausal women: Relationship with body weight regulation.
Progress in Neuro-Psychopharmacology and Biological Psychiatry,
Vol. 24,
Issue. 1,
p.
1.
Greenwood, Robert S.
2000.
Adverse Effects of Antiepileptic Drugs.
Epilepsia,
Vol. 41,
Issue. s2,
Harvey, Brian H.
and
Bouwer, Colin D.
2000.
Neuropharmacology of Paradoxic Weight Gain with Selective Serotonin Reuptake Inhibitors.
Clinical Neuropharmacology,
Vol. 23,
Issue. 2,
p.
90.
Arroyo, Santiago
and
Kramer, G??nter
2001.
Treating Epilepsy in the Elderly.
Drug Safety,
Vol. 24,
Issue. 13,
p.
991.
Genton, Pierre
Bauer, Jürgen
Duncan, Susan
Taylor, Ann E.
Balen, Adam H.
Eberle, Andrea
Pedersen, Birthe
Salas‐Puig, Xavier
and
Sauer, Mark V.
2001.
On the Association Between Valproate and Polycystic Ovary Syndrome.
Epilepsia,
Vol. 42,
Issue. 3,
p.
295.
Ueberall, Michael A
2001.
Normal growth during lamotrigine monotherapy in pediatric epilepsy patients — a prospective evaluation of 103 children and adolescents.
Epilepsy Research,
Vol. 46,
Issue. 1,
p.
63.
Biton, V.
Mirza, W.
Montouris, G.
Vuong, A.
Hammer, A.E.
and
Barrett, P.S.
2001.
Weight change associated with valproate and lamotrigine monotherapy in patients with epilepsy.
Neurology,
Vol. 56,
Issue. 2,
p.
172.
Baptista, Trino
Lacruz, Anny
Meza, Teraiza
Contreras, Quilianio
Delgado, Carlos
Mejìas, Maria A
and
Hernàndez, Luis
2001.
Antipsychotic Drugs and Obesity: Is Prolactin Involved?.
The Canadian Journal of Psychiatry,
Vol. 46,
Issue. 9,
p.
829.
Verrotti, Alberto
Basciani, Fania
De Simone, Michele
Trotta, Daniela
Morgese, Guido
and
Chiarelli, Francesco
2002.
Insulin Resistance in Epileptic Girls Who Gain Weight After Therapy With Valproic Acid.
Journal of Child Neurology,
Vol. 17,
Issue. 4,
p.
265.
Bauer, J.
2002.
Valproinsäure.
p.
342.
Walden, J.
Grunze, H.
Dose, M.
and
Emrich, H. M.
2002.
Neuro-Psychopharmaka Ein Therapie-Handbuch.
p.
863.
Sheth, Raj D.
2002.
Adolescent Issues in Epilepsy.
Journal of Child Neurology,
Vol. 17,
Issue. 2_suppl,
p.
2S23.
Gidal, Barry E
Sheth, Raj D
Magnus, Leslie
and
Herbeuval, Anne-Francoise
2003.
Levetiracetam does not alter body weight: analysis of randomized, controlled clinical trials.
Epilepsy Research,
Vol. 56,
Issue. 2-3,
p.
121.
Biton, Victor
Levisohn, Paul
Hoyler, Sheri
Vuong, Alain
and
Hammer, Anne E.
2003.
Lamotrigine Versus Valproate Monotherapy—Associated Weight Change in Adolescents With Epilepsy: Results From a Post Hoc Analysis of a Randomized, Double-Blind Clinical Trial.
Journal of Child Neurology,
Vol. 18,
Issue. 2,
p.
133.
Røste, L. S.
Taubøll, E.
Haugen, T. B.
Bjørnenak, T.
Sætre, E. R.
and
Gjerstad, L.
2003.
Alterations in semen parameters in men with epilepsy treated with valproate or carbamazepine monotherapy.
European Journal of Neurology,
Vol. 10,
Issue. 5,
p.
501.